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Type 1 diabetes mellitus (T1DM) is one of the most com-
mon chronic diseases in young patients. Characteristic 
circulating, islet-specific pancreatic autoantibodies may 
be present [against insulin, glutamic acid decarboxylase 
65 (GAD65), zinc transporter 8 (ZnT8), 40k fragment of 
tyrosine phosphatase (IA2)] [1], and they can lead to in-
sulin deficiency. Patients with T1DM can develop other 
organ-specific autoantibodies, causing autoimmune 
thyroiditis, coeliac disease, or pernicious anaemia, or 
patients with the mentioned diseases can often develop 
autoantibodies characteristic to Hashimoto’s thyroiditis 
[2]. At least 2 organ-specific autoimmune diseases can 
be part of autoimmune polyendocrine/polyglandular 
syndromes (APS) (Tab. 1).
A 32-year-old male patient with diabetes mellitus 
presented to ambulatory care because of suboptimal 
blood sugar levels, alleged weight loss, vague low-back 
pain, and supposed malabsorption. The patient history 
contained 3 years’ history of T1DM, 2 years’ history of 
thyroid disease, and mitral and aortic valve prolapse. 
The patient’s mother had Hashimoto’s thyroiditis and 
myasthenia gravis. On physical examination, the pa-
tient was underweight (height 180 cm, weight 52 kg, 
BMI: 16 kg/m2). His posture, and long limbs and fingers 
suggested marfanoid habitus. Antibody levels were 
high (Tab. 2). Based on low BMI, relatively young age, 
and islet-specific antibody positivity, we could confirm 
the diagnosis of T1DM. 
Laboratory values and sonographic morphology 
were consistent with a euthyroid Hashimoto’s thy-
roiditis (Fig. 1A).
The laboratory tests performed at admission 
showed mild, macrocytic anaemia. Vitamin B12 level 
was below the reference range. Gastroscopy showed 
type A atrophic gastritis, and histological evaluation 
revealed severe chronic gastritis with intestinal meta-
plasia without H. pylori infection. Immunological tests 
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table 1. Autoimmune polyglandular syndromes





















 2 Autoimmune adrenal 
insufficiency, autoimmune 
thyroid disease  
and/or T1DM
Vitiligo, autoimmune hepatitis, 







Autoimmune thyroid disease and at least one other 
organ-specific autoimmune disorder, e.g. T1DM, primary 
hypogonadism, pernicious anaemia, coeliac disease, 
vitiligo, alopecia, psoriasis that is not Addison’s disease 
or hypoparathyroidism
APS — autoimmune polyglandular syndrome; T1DM — type 1 diabetes mellitus
table 2. Laboratory results
Value Reference range
Anti-GAD 1745 IU/mL < 10 IU/mL
Anti-ZnT8 17 IU/mL < 15 IU/mL
ATPO 1196 U/mL < 5.6 U/mL
Vitamin B12 72 pmol/L 138–652 pmol/L
Homocysteine 100.2 µmol/L 5.4–16 µmol/L
anti-GAD — anti-glutamic acid decarboxylase antibody; anti-ZnT8 — anti-zinc 
transporter 8 antibody; ATPO — anti-thyroid peroxidase antibody
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genetic analysis of the 2 most frequent mutations of the 
methylenetetrahydrofolate reductase (MTHFR) gene. 
We found the A1298C mutation in homozygous variant 
[MTHFR (methylenetetrahydrofolate reductase) C677T 
normal variant, MTHFR A1298C homozygous variant)]. 
Therefore, we concluded that the elevated homocyste-
ine level may be explained by vitamin B12 deficiency 
and the patient’s genetic predisposition.
The young patient has type 3 APS. The cardiovascular 
risk of the patient is higher because of the T1DM. El-
evated homocysteine levels are associated with higher 
cardiovascular risk and more frequent thromboembolic 
events; moreover, homocysteine is an independent risk 
factor of cardiovascular diseases [3]. Approximately 
10% of the US population are homozygous for the 
thermolabile variant of MTHFR (C677T), and 30% are 
heterozygous for another polymorphism of MTHFR 
gene; A1298C is found in approximately 10% of the 
Caucasian population [4]. There is no clear consensus 
on whether reducing the homocysteine level through 
vitamin B12 replacement lowers the cardiovascular risk 
[5]. We observed genetic alteration independent of the 
comorbidities of type 1 diabetes mellitus.
In conclusion, in patients with type 1 diabetes mellitus 
and with autoimmune polyglandular syndrome, who 
have higher cardiovascular risk, the presence of other 
genetically known risk factors, such as hyperhomocys-
teinaemia or spondylarthritis, should be considered, in 
order to initiate preventive measures.
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were also performed. Anti-parietal cell antibodies tested 
positive, while antibodies against intrinsic factor were 
negative. Thus, the diagnosis of pernicious anaemia 
could be established. 
The patient had vitamin B12 malabsorption. 
However, iron-, lipid-, protein-, and calcium/vitamin 
D3-metabolism were without marked alterations. Co-
eliac disease could also be excluded because of the 
negativity of antibodies against tissue transglutamin-
ase and deamidated gliadin peptides. Gastroscopy 
showed no typical signs of coeliac disease in the small 
intestine. There were no ionic disturbances, the fast-
ing serum cortisol level was within the normal range, 
and no clinical signs of hypoadrenalism were detected; 
therefore, we could rule out clinically manifested Ad-
dison’s disease. 
Concurrent Hashimoto’s thyroiditis, T1DM, and 
pernicious anaemia, and the absence of Addison’s 
disease and hypoparathyroidism, suggested the diag-
nosis of type 3 autoimmune polyendocrine syndrome. 
Maternal anamnesis of Hashimoto’s thyroiditis and 
myasthenia gravis that could be diagnosed also as APS3, 
strengthens the diagnosis. 
We performed further tests because of the mar-
fanoid habitus and valvular prolapses of the patient. 
Because of the vague low-back pain and the character-
istic phenotype of the patient, we performed tests to 
evaluate ankylosing spondylitis (AS). There was no clear 
sign of sacroiliitis on plain pelvic X-ray (Fig. 1B). From 
the 11 characteristic ankylosing spondylitis symptoms, 
the patient showed only 1, namely HLA-B27 positivity. 
According to the relevant guideline, sacroiliitis on MRI 
would further strengthen the diagnosis, but it is itself 
not diagnostic. Because of vitamin B12 deficiency, the 
patient’s homocysteine level was measured and was 
found to be extremely elevated. B12 and folate-depen-
dent enzymatic conversions are responsible for keep-
ing homocysteine levels relatively low by conversion 
to methionine or cysteine. We therefore performed 
Figure 1a. Sonographic image of the hypervascularized thyroid 
gland. B. There is no clear sign of sacroiliitis on the pelvic X-ray
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